Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9545 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9018 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9018 |
High Similarity |
NPD7054 |
Approved |
0.8963 |
High Similarity |
NPD7472 |
Approved |
0.8916 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.891 |
High Similarity |
NPD4380 |
Phase 2 |
0.8909 |
High Similarity |
NPD6797 |
Phase 2 |
0.8855 |
High Similarity |
NPD7251 |
Discontinued |
0.8848 |
High Similarity |
NPD7074 |
Phase 3 |
0.8841 |
High Similarity |
NPD3818 |
Discontinued |
0.8802 |
High Similarity |
NPD7808 |
Phase 3 |
0.8734 |
High Similarity |
NPD7411 |
Suspended |
0.8718 |
High Similarity |
NPD5403 |
Approved |
0.8696 |
High Similarity |
NPD7075 |
Discontinued |
0.8679 |
High Similarity |
NPD6801 |
Discontinued |
0.8634 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8631 |
High Similarity |
NPD6559 |
Discontinued |
0.8606 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8606 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8606 |
High Similarity |
NPD6166 |
Phase 2 |
0.859 |
High Similarity |
NPD5401 |
Approved |
0.8562 |
High Similarity |
NPD1549 |
Phase 2 |
0.8526 |
High Similarity |
NPD6799 |
Approved |
0.8509 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8383 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8353 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8314 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8314 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8282 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8192 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8171 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8171 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8133 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8101 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8101 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7987 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7975 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7965 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7962 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7912 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7875 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7819 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7803 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.768 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7656 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7656 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7592 |
Intermediate Similarity |
NPD7585 |
Approved |
0.759 |
Intermediate Similarity |
NPD920 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7528 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7526 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7474 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7471 |
Intermediate Similarity |
NPD37 |
Approved |
0.7469 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7418 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7409 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7356 |
Intermediate Similarity |
NPD919 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7344 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7296 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7283 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7273 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7253 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7234 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7228 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD943 |
Approved |
0.7204 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7191 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7189 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD447 |
Suspended |
0.716 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7079 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD9493 |
Approved |
0.6988 |
Remote Similarity |
NPD5406 |
Approved |
0.6988 |
Remote Similarity |
NPD5404 |
Approved |
0.6988
|
Remote Similarity |
NPD5405 |
Approved |